Charles Homcy, M.D.

Charles Homcy, M.D.

DirectoratMaze Therapeutics· In proxies 2023–2025

Charles Homcy, M.D. sits on 7 public boards.

Boards2

  • Maze TherapeuticsDirector · 7 yr on the boardNot independentNominating and Corporate Governance—Paid as an executive
  • BridgeBio PharmaDirector · 6 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Maze TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role +99%
  2. BridgeBio PharmaPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. PharmaceuticalsPublic company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  4. Maze Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Global Blood Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Pliant Therapeutics, Inc.Public company · 7 yr
    • Director2015 – 2022 · 7 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?